Cytokinetics | CYTK - 股本和储备



金融业
股票价格
USD
资产
USD 1.27B
现金及等价物
USD 129.84M
销售成本
USD 160K
流动资产
USD 839.47M
流动负债
USD 199.19M
债务
USD 1.29B
EBIT
USD -181.23M
EBITDA
USD -169.32M
员工
498
EPS每股收益
USD -1.67
股本和储备
USD -826.57M
销售毛利
USD 19.2M
债务利息支出
USD 33.34M
利息收入
USD 11.02M
贷款资金
USD 247.21M
市值
USD 9.46B
净收入
USD -206.03M
营业费用
USD 200.58M
营业利润
USD -181.23M
普通股股本
USD 124.43M
税前利润
USD -206.03M
销售收入
USD 19.35M
销售和管理费用
USD 104.9M
股票
USD 154K
贸易债权人
USD 24.71M
应收帐款人
USD 6.83M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Amgen USD 9.19B 532M 2026-03
Arca Biopharma USD 486.72M 17.72M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.65B 394.9M 2026-03
Brainstorm Cell Therapeutics USD -11.01M 1.02M 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
Capricor Therapeutics USD 278.7M 27.09M 2026-03
Cytokinetics USD -826.57M 166.94M 2026-03
Eisai JPY 898.99B 9.36B 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Exelixis USD 1.94B 225.57M 2026-03
Geron USD 229.11M 3.24M 2026-03
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Ligand Pharmaceuticals USD 997.32M 19.89M 2026-03
Merck USD 45.88B 6.73B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03